Optimal Control of the Primary Drying Stage of Freeze Drying of Solutions in Vials Using Variational Calculus

The problem of operating freeze drying of pharmaceutical products in vials placed in trays of a freeze dryer to remove free water (in frozen state) at a minimum time was formulated as an optimal control problem. Two different types of freeze dryer designs were considered. In type I freeze dryer design, upper and lower plate temperatures were controlled together, while in type II freeze dryer design, upper and lower plate temperatures were controlled independently. The heat input to the material being dried and the drying chamber pressure were considered as control variables. Constraints were placed on the system state variables by the melting and scorch temperatures during primary drying stage. Necessary conditions of optimality for the primary drying stage of freeze drying process in vials are derived and presented. Furthermore, an approach for constructing the optimal control policies that would minimize the drying time for the primary drying stage was given. In order to analyze optimal control policy for the primary drying stage of the freeze-drying process in vials, a rigorous multi-dimensional unsteady state mathematical model was used. The theoretical approach presented in this work was applied in the freeze drying of skim milk. Significant reductions in the drying times of primary drying stage of freeze drying process in vials were obtained, as compared to the drying times obtained from conventional operational policies.     

β-环糊精-氧化石墨烯超分子杂化体的构筑及应用进展

β-环糊精是由7个D-吡喃葡萄糖单元通过α-1,4-糖苷键键连成环的超分子主体分子，“内疏水、外亲水”的独特结构赋予了其优异的分子识别能力；氧化石墨烯类材料凭借其优良特性成为近几年的研究热点。由β-环糊精和氧化石墨烯构筑的超分子杂化体在兼具二者特有性能的基础上又有新功能的引入。本文综述了β-环糊精-氧化石墨烯超分子杂化体的构筑方式，按二者间的连接方式，分别为共价键和非共价键两种连接方式，其中通过共价键连接是目前最主要的构筑方式；此外对β-环糊精-氧化石墨烯超分子杂化体的特征和表征进行了简述。同时对β-环糊精-氧化石墨烯超分子杂化体在水污染处理、电化学检测、药物控释和催化等领域的应用进展进行了综述。最后对该超分子杂化体在构筑和应用上的发展趋势进行了展望。     

对乙酰氨基酚的合成与生产

综述了国内外近年来对药物扑热息痛（对乙酰氨基酚）合成与生产方法的研究，主要介绍了二步法、一步法和生化法。提出了无论从经济上还是从环保上考虑，一步催化合成法是当今扑热息痛合成的出路     

国内外三聚氯氰的市场现状

世界三聚氯氰的生产企业主要有Degussa ,Syngenta和中国营口三征有机化学有限公司 ,2 0 0 2年世界三聚氯氰的生产能力为 2 2 33万t/a ,产量 11 4 16万t。截至 2 0 0 4年 5月 ,我国有三聚氯氰生产厂家 14家 ,实际开工 10家。 2 0 0 3年我国三聚氯氰的生产能力为 9 6 3万t/a ,产量 4 86 2万t,开工率 5 0 5 %。在我国 ,三聚氯氰的消费构成是三嗪类农药占 4 5 % ,染料占 30 % ,化学助剂占 18% ,医药占 2 % ,其他占 5 %。作者提出的发展建议是开发下游产品 ,促进产业发展 ;调整产业结构 ,实行大战略 ;增加出口量 ,占领国际市场。     

脉冲微分方程理论在药物动力学中的应用研究

为了揭示药物在机体内的ADME过程,将脉冲微分方程理论应用于研究药物动力学若干问题中,通过对系统动力学行为的研究进而设计最佳用药方案,丰富了脉冲微分方程理论并对指导临床实践具有积极意义.     

Research progress on preparation of biomass-derived porous carbon and its adsorption of pharmaceuticals in wastewater

The rapid development of urban modernization and industrialization has caused increasingly serious pollution to the environment, especially water contamination. In recent years, the content of pharmaceuticals in industrial wastewater has increased year by year, and the pollution should not be ignored any more. Therefore, the development of new porous materials for the adsorption and separation of pharmaceutical molecules in wastewater has become a current research hotspot. This article summarizes the recent research on the adsorption and separation of pollutants in wastewater by biomass-derived porous carbons (biochars). First, it briefly introduces the treatment methods of pollutants in wastewater, and mainly focuses on the preparation and modification of biochars. Combined with the surface chemical properties and pore structure of the carbon materials, this paper summarizes and prospects the adsorption properties of biochar to pharmaceuticals.     

Using RFID for the management of pharmaceutical inventory — system optimization and shrinkage control

Motivated by a case study at a radiology practice, we analyze the incremental benefits of RFID technology over barcodes for managing pharmaceutical inventories. Unlike barcode technology, RFID enables accurate real-time visibility, which in turn enables several process improvements. We analyze the impact of automatic counting and discuss the system redesign critical to optimizing the inventory policy and eliminating shrinkage. We show that continuous review is superior to periodic review whenever accurate real-time information is available at no additional cost. We explain how RFID-enabled strategies vary with inventory parameters and provide a cost-benefit analysis for the implementation of RFID for the radiology practice.     

口服制剂掩味方法的研究进展

综述了药物掩味方法的研究进展,对不同的技术进行了总结.开发药物制剂时,正确运用这些方法与技术,不影响药物的物理、化学稳定性和生物利用度.